Category: Editors’ Pick

Hospital Operator Tenet Healthcare ‘Not Overwhelmed’ With Coronavirus Cases

Tenet Healthcare said its more than 60 hospitals are “not being overwhelmed” by patients sickened by the Coronavirus strain COVID-19, a snapshot of how the U.S. healthcare system may be effectively coping with the pandemic.

Amazon VP Makes Million-Dollar Decision To Quit Over COVID-19 Warehouse Worker Firings

“I quit in dismay at Amazon firing whistleblowers who were making noise about warehouse employees frightened of Covid-19.”

The Grim Post-COVID-19 Future For Nursing Homes

COVID-19 is killing nursing home patients, but it also is putting thousands of facilities at risk

Google And Aerospace Industry To Boost Ventilator Production

Medical device makers have formed an alliance with Google and the aerospace industry to speed production and component part supplies needed to make ventilators for patients sickened COVID-19.

‘Murder Hornets’ Are Now In The U.S., What Does This Really Mean

The arrival of these Giant Hornets have generated a buzz. But how will this affect you?

This Costa Rican And His Robots Could Close California’s Coronavirus Testing Gap

In a robot-filled lab in California, a team including a scientist from Costa-Rica are working out how to use automation to do Coronavirus testing on a massive scale – a technology US states will need if they are going to ‘reopen’ safely. #globalsouthsc…

Travel ‘Under Own Steam’ Urges U.K. Transport Secretary Ahead Of Pop-Up Cycleways Funding Plan

U. K. transport secretary Grant Shapps could announce emergency funding to enable local authorities to pay for “pop-up” cycling and walking infrastructure to enable physical distancing during lockdown.

Can COVID-19 Coronavirus Live In Water? What About Drinking Water And Swimming

Here is what a lab study and a sewage water study in Paris, France, found. And here is what to do once beaches and swimming pools re-open.

Insurers Brace For Big Influx Of Jobless Americans To Obamacare And Medicaid

Health insurers are preparing for an influx of Americans to enroll in Obamacare and private Medicaid as Americans lose their jobs and employer health benefits.

Large-Scale Clinical Trials Of Mesoblast’s Stem Cell Treatment For COVID-19 Set To Begin Soon

Melbourne-based biotech company Mesoblast will enroll up to 300 COVID-19 patients for a randomized, controlled study of its stem cell therapy.